Rules Navigator

Sign in
Register

FDA launches unified adverse event reporting dashboard

A photo of FDA sign on lawn at agency headquarters.
Photo: Sarah Silbiger/Getty Images

Kevin Kinsella

1 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

In addition to consolidating adverse events for all regulated products, the new centralized platform will manage consumer complaints, regulatory misconduct reports, and whistleblower submissions.

A new unified reporting and monitoring platform will process adverse-event reports ​submitted to the US Federal Drug Administration (FDA) for drugs, biologics, vaccines, cosmetics, ​and animal food on a single dashboard.

The ‌new platform is called the ⁠FDA Adverse Event Monitoring System (AEMS), and will contain real-time adverse-event reports ​for

Register for free to keep reading

To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.

  • Unlimited access to industry insights
  • Stay on top of key rules and regulatory changes with our Rules Navigator
  • Ad-free experience with no distractions
  • Regular podcasts from trusted external experts
  • Fresh compliance and regulatory content every day
Register for free
Sign in
, , , , , ,